share_log

Jefferies Upgrades Vera Therapeutics to Buy, Raises Price Target to $26

Jefferies Upgrades Vera Therapeutics to Buy, Raises Price Target to $26

杰富瑞集团上调Vera Therapeutics的买入,将目标股价提高至26美元
Benzinga ·  2023/11/10 05:31

Jefferies analyst Farzin Haque upgrades Vera Therapeutics (NASDAQ:VERA) from Hold to Buy and raises the price target from $18 to $26.

杰富瑞分析师法尔津·哈克将Vera Therapeutics(纳斯达克股票代码:VERA)从持有上调至买入,并将目标股价从18美元上调至26美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发